-
1
-
-
34247526419
-
Mitochondrial dynamics in disease
-
[1] Chan DC. Mitochondrial dynamics in disease. N Engl J Med 2007; 356: 1707-9.
-
(2007)
N Engl J Med
, vol.356
, pp. 1707-1709
-
-
Chan, D.C.1
-
2
-
-
33750428601
-
Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants
-
[2] Moreno-Loshuertos R, Acín-Pérez R, Fernández-Silva P, et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 2006; 38: 1261-8.
-
(2006)
Nat Genet
, vol.38
, pp. 1261-1268
-
-
Moreno-Loshuertos, R.1
Acín-Pérez, R.2
Fernández-Silva, P.3
-
3
-
-
79955592354
-
Evolution meets disease: Penetrance and functional epistasis of mitochondrial tRNA mutations
-
[3] Moreno-Loshuertos R, Ferrín G, Acín-Pérez R, et al. Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations. PLoS Genet 2011; 7: e1001379.
-
(2011)
Plos Genet
, vol.7
-
-
Moreno-Loshuertos, R.1
Ferrín, G.2
Acín-Pérez, R.3
-
4
-
-
33644749330
-
Activation of AMPactivated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells
-
[4] Kukidome D, Nishikawa T, Sonoda K, et al. Activation of AMPactivated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006; 55: 120-7.
-
(2006)
Diabetes
, vol.55
, pp. 120-127
-
-
Kukidome, D.1
Nishikawa, T.2
Sonoda, K.3
-
5
-
-
58149328569
-
Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1
-
[5] Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008; 103: 1232-40.
-
(2008)
Circ Res
, vol.103
, pp. 1232-1240
-
-
Piantadosi, C.A.1
Carraway, M.S.2
Babiker, A.3
Suliman, H.B.4
-
7
-
-
0033126367
-
Impaired energy metabolism in hearts of septic baboons: Diminished activities of Complex I and Complex II of the mitochondrial respiratory chain
-
[7] Gellerich FN, Trumbeckaite S, Hertel K, et al. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock, 1999; 11: 336-41.
-
(1999)
Shock
, vol.11
, pp. 336-341
-
-
Gellerich, F.N.1
Trumbeckaite, S.2
Hertel, K.3
-
8
-
-
1242275126
-
Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia
-
[8] Crouser ED, Julian MW, Huff JE, et al. Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit Care Med 2004; 32: 478-88.
-
(2004)
Crit Care Med
, vol.32
, pp. 478-488
-
-
Crouser, E.D.1
Julian, M.W.2
Huff, J.E.3
-
9
-
-
0026544127
-
Chronic hyperdynamic sepsis in the rat. II. Characterization of liver and muscle energy metabolism
-
[9] Mela-Riker L, Bartos D, Vlessis AA, Widener L, Muller P, Trunkey DD. Chronic hyperdynamic sepsis in the rat. II. Characterization of liver and muscle energy metabolism. Circ Shock, 1992; 36: 83-92.
-
(1992)
Circ Shock
, vol.36
, pp. 83-92
-
-
Mela-Riker, L.1
Bartos, D.2
Vlessis, A.A.3
Widener, L.4
Muller, P.5
Trunkey, D.D.6
-
10
-
-
0028870087
-
Reactive oxygen species produced by liver mitochondria of rats in sepsis
-
[10] Taylor DE, Ghio AJ, Piantadosi CA. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys, 1995; 316: 70-6.
-
(1995)
Arch Biochem Biophys
, vol.316
, pp. 70-76
-
-
Taylor, D.E.1
Ghio, A.J.2
Piantadosi, C.A.3
-
11
-
-
0031868271
-
Mitochondrial respiration after sepsis and prolonged hypoxia
-
[11] Taylor DE, Kantrow SP, Piantadosi CA. Mitochondrial respiration after sepsis and prolonged hypoxia. Am J Physiol, 1998; 275: L139-44.
-
(1998)
Am J Physiol
, vol.275
, pp. 44-139
-
-
Taylor, D.E.1
Kantrow, S.P.2
Piantadosi, C.A.3
-
12
-
-
0141920307
-
Changes of proton transportation across the inner mitochondrial membrane and H(+)-ATPase in endotoxic shock rats
-
[12] Lu SM, Song SM, Liu JC, Yang HM, Li P, Wang ZG. Changes of proton transportation across the inner mitochondrial membrane and H(+)-ATPase in endotoxic shock rats. Chin J Traumatol 2003; 6: 292-6.
-
(2003)
Chin J Traumatol
, vol.6
, pp. 292-296
-
-
Lu, S.M.1
Song, S.M.2
Liu, J.C.3
Yang, H.M.4
Li, P.5
Wang, Z.G.6
-
13
-
-
59249103567
-
Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia
-
[13] Reynolds CM, Suliman HB, Hollingsworth JW, Welty-Wolf KE, Carraway MS, Piantadosi CA. Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia. Free Radic Biol Med 2009; 46: 564-72.
-
(2009)
Free Radic Biol Med
, vol.46
, pp. 564-572
-
-
Reynolds, C.M.1
Suliman, H.B.2
Hollingsworth, J.W.3
Welty-Wolf, K.E.4
Carraway, M.S.5
Piantadosi, C.A.6
-
14
-
-
77951839683
-
Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice
-
[14] Ahuja P, Zhao P, Angelis E, et al. Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J Clin Invest 2010; 120: 1494-505.
-
(2010)
J Clin Invest
, vol.120
, pp. 1494-1505
-
-
Ahuja, P.1
Zhao, P.2
Angelis, E.3
-
15
-
-
39849094082
-
Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism
-
[15] Gutsaeva DR, Carraway MS, Suliman HB, et al. Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J Neurosci 2008; 28: 2015-24.
-
(2008)
J Neurosci
, vol.28
, pp. 2015-2024
-
-
Gutsaeva, D.R.1
Carraway, M.S.2
Suliman, H.B.3
-
16
-
-
84866295745
-
Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice
-
[16] Athale J, Ulrich A, Chou Macgarvey N, et al. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med 2012; 53: 1584-94.
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 1584-1594
-
-
Athale, J.1
Ulrich, A.2
Chou Macgarvey, N.3
-
17
-
-
33847306780
-
Signaling of mitochondrial biogenesis following oxidant injury
-
[17] Rasbach KA, Schnellmann RG. Signaling of mitochondrial biogenesis following oxidant injury. J Biol Chem 2007; 282: 2355-62.
-
(2007)
J Biol Chem
, vol.282
, pp. 2355-2362
-
-
Rasbach, K.A.1
Schnellmann, R.G.2
-
18
-
-
76749130118
-
5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis
-
[18] Rasbach KA, Funk JA, Jayavelu T, Green PT, Schnellmann RG. 5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J Pharmacol Exp Ther 2010; 332: 632-9.
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 632-639
-
-
Rasbach, K.A.1
Funk, J.A.2
Jayavelu, T.3
Green, P.T.4
Schnellmann, R.G.5
-
20
-
-
0142039781
-
Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1
-
[20] Suliman HB, Carraway MS, Welty-Wolf KE, Whorton AR, Piantadosi CA. Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1. J Biol Chem 2003; 278: 41510-8.
-
(2003)
J Biol Chem
, vol.278
, pp. 41510-41518
-
-
Suliman, H.B.1
Carraway, M.S.2
Welty-Wolf, K.E.3
Whorton, A.R.4
Piantadosi, C.A.5
-
21
-
-
5444246214
-
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
-
[21] Suliman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 2004; 64: 279-88.
-
(2004)
Cardiovasc Res
, vol.64
, pp. 279-288
-
-
Suliman, H.B.1
Welty-Wolf, K.E.2
Carraway, M.3
Tatro, L.4
Piantadosi, C.A.5
-
22
-
-
24644490059
-
Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heatinactivated E. Coli
-
[22] Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, Piantadosi CA. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heatinactivated E. coli. FASEB J 2005; 19: 1531-3.
-
(2005)
FASEB J
, vol.19
, pp. 1531-1533
-
-
Suliman, H.B.1
Welty-Wolf, K.E.2
Carraway, M.S.3
Schwartz, D.A.4
Hollingsworth, J.W.5
Piantadosi, C.A.6
-
23
-
-
35349015667
-
Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis
-
[23] Haden DW, Suliman HB, Carraway MS, et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med 2007; 176: 768-77.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 768-777
-
-
Haden, D.W.1
Suliman, H.B.2
Carraway, M.S.3
-
24
-
-
34548176581
-
Mitochondrial function in sepsis: Acute phase versus multiple organ failure
-
[24] Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 2007; 35: S441-8.
-
(2007)
Crit Care Med
, vol.35
, pp. 48-441
-
-
Singer, M.1
-
25
-
-
77957041807
-
Survival in critical illness is associated with early activation of mitochondrial biogenesis
-
[25] Carré JE, Orban JC, Re L, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010; 182: 745-51.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 745-751
-
-
Carré, J.E.1
Orban, J.C.2
Re, L.3
-
26
-
-
77955351652
-
New insights into the role of mitochondria in aging: Mitochondrial dynamics and more
-
[26] Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 2010; 123: 2533-42.
-
(2010)
J Cell Sci
, vol.123
, pp. 2533-2542
-
-
Seo, A.Y.1
Joseph, A.M.2
Dutta, D.3
Hwang, J.C.4
Aris, J.P.5
Leeuwenburgh, C.6
-
27
-
-
56249143798
-
Assessing mitochondria biogenesis
-
[27] Medeiros DM. Assessing mitochondria biogenesis. Methods 2008; 46: 288-94.
-
(2008)
Methods
, vol.46
, pp. 288-294
-
-
Medeiros, D.M.1
-
28
-
-
33749247065
-
Transducer of regulated CREBbinding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells
-
[28] Wu Z, Huang X, Feng Y, et al. Transducer of regulated CREBbinding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci USA 2006; 103: 14379-84.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 14379-14384
-
-
Wu, Z.1
Huang, X.2
Feng, Y.3
-
29
-
-
77951049870
-
SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells
-
[29] Funk JA, Odejinmi S, Schnellmann RG. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J Pharmacol Exp Ther 2010; 333: 593-601.
-
(2010)
J Pharmacol Exp Ther
, vol.333
, pp. 593-601
-
-
Funk, J.A.1
Odejinmi, S.2
Schnellmann, R.G.3
-
31
-
-
75149138678
-
Nitric oxide synthase-2 regulates mitochondrial Hsp60 chaperone function during bacterial peritonitis in mice
-
[31] Suliman HB, Babiker A, Withers CM, et al. Nitric oxide synthase-2 regulates mitochondrial Hsp60 chaperone function during bacterial peritonitis in mice. Free Radic Biol Med 2010; 48: 736-46.
-
(2010)
Free Radic Biol Med
, vol.48
, pp. 736-746
-
-
Suliman, H.B.1
Babiker, A.2
Withers, C.M.3
-
32
-
-
77952889195
-
The multiple actions of NO
-
[32] Gao Y. The multiple actions of NO. Pflugers Arch 2010; 459: 829-39.
-
(2010)
Pflugers Arch
, vol.459
, pp. 829-839
-
-
Gao, Y.1
-
33
-
-
0347579845
-
Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide
-
[33] Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003; 299: 896-9.
-
(2003)
Science
, vol.299
, pp. 896-899
-
-
Nisoli, E.1
Clementi, E.2
Paolucci, C.3
-
34
-
-
34250700076
-
Nitric oxide and mitochondrial respiration in the heart
-
[34] Brown GC, Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 2007; 75: 283-90.
-
(2007)
Cardiovasc Res
, vol.75
, pp. 283-290
-
-
Brown, G.C.1
Borutaite, V.2
-
35
-
-
10044230387
-
On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide
-
[35] Antunes F, Boveris A, Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc Natl Acad Sci USA 2004; 101: 16774-9.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 16774-16779
-
-
Antunes, F.1
Boveris, A.2
Cadenas, E.3
-
36
-
-
64749103648
-
The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide
-
[36] Poderoso JJ. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 2009; 484: 214-20.
-
(2009)
Arch Biochem Biophys
, vol.484
, pp. 214-220
-
-
Poderoso, J.J.1
-
37
-
-
33846863589
-
Nitric oxide and peroxynitrite in health and disease
-
[37] Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
-
(2007)
Physiol Rev
, vol.87
, pp. 315-424
-
-
Pacher, P.1
Beckman, J.S.2
Liaudet, L.3
-
38
-
-
33746841367
-
Nitric oxide and mitochondrial biogenesis
-
[38] Nisoli E, Carruba MO. Nitric oxide and mitochondrial biogenesis. J Cell Sci 2006; 119: 2855-62.
-
(2006)
J Cell Sci
, vol.119
, pp. 2855-2862
-
-
Nisoli, E.1
Carruba, M.O.2
-
39
-
-
77956722579
-
Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells
-
[39] Lira VA, Brown DL, Lira AK, et al. Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells. J Physiol 2010; 588: 3551-66.
-
(2010)
J Physiol
, vol.588
, pp. 3551-3566
-
-
Lira, V.A.1
Brown, D.L.2
Lira, A.K.3
-
40
-
-
9344220484
-
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
-
[40] Nisoli E, Falcone S, Tonello C, et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 2004; 101: 16507-12.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 16507-16512
-
-
Nisoli, E.1
Falcone, S.2
Tonello, C.3
-
41
-
-
34250159850
-
The role of nitric oxide in muscle fibers with oxidative phosphorylation defects
-
[41] Tengan CH, Kiyomoto BH, Godinho RO, et al. The role of nitric oxide in muscle fibers with oxidative phosphorylation defects. Biochem Biophys Res Commun 2007; 359: 771-7.
-
(2007)
Biochem Biophys Res Commun
, vol.359
, pp. 771-777
-
-
Tengan, C.H.1
Kiyomoto, B.H.2
Godinho, R.O.3
-
43
-
-
84862505871
-
Characterization of the role of nitric oxide and its clinical applications
-
[43] Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012; 122: 55-68.
-
(2012)
Cardiology
, vol.122
, pp. 55-68
-
-
Levine, A.B.1
Punihaole, D.2
Levine, T.B.3
-
44
-
-
55749115090
-
Resistance training in patients with single, large-scale deletions of mitochondrial DNA
-
[44] Murphy JL, Blakely EL, Schaefer AM, et al. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 2008; 131: 2832-40.
-
(2008)
Brain
, vol.131
, pp. 2832-2840
-
-
Murphy, J.L.1
Blakely, E.L.2
Schaefer, A.M.3
-
45
-
-
84867895466
-
Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders
-
[45] El-Hattab AW, Emrick LT, Craigen WJ, Scaglia F. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol Genet Metab 2012; 107: 247-52.
-
(2012)
Mol Genet Metab
, vol.107
, pp. 247-252
-
-
El-Hattab, A.W.1
Emrick, L.T.2
Craigen, W.J.3
Scaglia, F.4
-
46
-
-
13844321746
-
L-arginine improves the symptoms of strokelike episodes in MELAS
-
[46] Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005; 64: 710-2.
-
(2005)
Neurology
, vol.64
, pp. 710-712
-
-
Koga, Y.1
Akita, Y.2
Nishioka, J.3
-
47
-
-
84858700111
-
Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation
-
[47] El-Hattab AW, Hsu JW, Emrick LT, et al. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet Metab 2012; 105: 607-14.
-
(2012)
Mol Genet Metab
, vol.105
, pp. 607-614
-
-
El-Hattab, A.W.1
Hsu, J.W.2
Emrick, L.T.3
-
48
-
-
14844303949
-
Hypocitrullinemia in patients with MELAS: An insight into the "MELAS paradox"
-
[48] Naini A, Kaufmann P, Shanske S, Engelstad K, De Vivo DC, Schon EA. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci 2005; 229-230: 187-93.
-
(2005)
J Neurol Sci
, vol.229-230
, pp. 187-193
-
-
Naini, A.1
Kaufmann, P.2
Shanske, S.3
Engelstad, K.4
De Vivo, D.C.5
Schon, E.A.6
-
49
-
-
33745648369
-
Endothelial dysfunction in MELAS improved by l-arginine supplementation
-
[49] Koga Y, Akita Y, Junko N, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006; 66: 1766-9.
-
(2006)
Neurology
, vol.66
, pp. 1766-1769
-
-
Koga, Y.1
Akita, Y.2
Junko, N.3
-
50
-
-
33846043968
-
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy
-
[50] Brunelli S, Sciorati C, D'Antona G, et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci USA 2007; 104: 264-9.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 264-269
-
-
Brunelli, S.1
Sciorati, C.2
D'antona, G.3
-
51
-
-
33646234945
-
Persistent and improved functional gain in mdx dystrophic mice after treatment with Larginine and deflazacort
-
[51] Archer JD, Vargas CC, Anderson JE. Persistent and improved functional gain in mdx dystrophic mice after treatment with Larginine and deflazacort. FASEB J 2006; 20: 738-40.
-
(2006)
FASEB J
, vol.20
, pp. 738-740
-
-
Archer, J.D.1
Vargas, C.C.2
Erson, J.E.3
-
52
-
-
84856119982
-
Nitric oxide sustains longterm skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP
-
[52] Buono R, Vantaggiato C, Pisa V, et al. Nitric oxide sustains longterm skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 2012; 30: 197-209.
-
(2012)
Stem Cells
, vol.30
, pp. 197-209
-
-
Buono, R.1
Vantaggiato, C.2
Pisa, V.3
-
53
-
-
77956605222
-
Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease
-
[53] Cadenas S, Aragonés J, Landázuri MO. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc Res 2010; 88: 219-28.
-
(2010)
Cardiovasc Res
, vol.88
, pp. 219-228
-
-
Cadenas, S.1
Aragonés, J.2
Landázuri, M.O.3
-
54
-
-
78649690856
-
Effects of long term nitrite therapy on functional recovery in experimental ischemia model
-
[54] Jung KH, Chu K, Lee ST, et al. Effects of long term nitrite therapy on functional recovery in experimental ischemia model. Biochem Biophys Res Commun 2010; 403: 66-72.
-
(2010)
Biochem Biophys Res Commun
, vol.403
, pp. 66-72
-
-
Jung, K.H.1
Chu, K.2
Lee, S.T.3
-
55
-
-
53149154867
-
Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis
-
[55] Vieira HL, Queiroga CS, Alves PM. Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis. J Neurochem 2008; 107: 375-84.
-
(2008)
J Neurochem
, vol.107
, pp. 375-384
-
-
Vieira, H.L.1
Queiroga, C.S.2
Alves, P.M.3
-
56
-
-
77955915244
-
Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury
-
[56] Biermann J, Lagrèze WA, Dimitriu C, Stoykow C, Goebel U. Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury. Invest Ophthalmol Vis Sci 2010; 51: 3784-91.
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, pp. 3784-3791
-
-
Biermann, J.1
Lagrèze, W.A.2
Dimitriu, C.3
Stoykow, C.4
Goebel, U.5
-
57
-
-
48549090696
-
Carbon monoxide, reactive oxygen signaling, and oxidative stress
-
[57] Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008; 45: 562-9.
-
(2008)
Free Radic Biol Med
, vol.45
, pp. 562-569
-
-
Piantadosi, C.A.1
-
58
-
-
77956323967
-
The therapeutic potential of carbon monoxide
-
[58] Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010; 9: 728-43.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 728-743
-
-
Motterlini, R.1
Otterbein, L.E.2
-
59
-
-
79955542142
-
Heme oxygenase-1 couples activation of mitochondrial biogenesis to antiinflammatory cytokine expression
-
[59] Piantadosi CA, Withers CM, Bartz RR, et al. Heme oxygenase-1 couples activation of mitochondrial biogenesis to antiinflammatory cytokine expression. J Biol Chem 2011; 286: 16374-85.
-
(2011)
J Biol Chem
, vol.286
, pp. 16374-16385
-
-
Piantadosi, C.A.1
Withers, C.M.2
Bartz, R.R.3
-
60
-
-
75549091881
-
Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use
-
[60] Bauer I, Pannen BH. Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use. Crit Care 2009; 13: 220.
-
(2009)
Crit Care
, vol.13
, pp. 220
-
-
Bauer, I.1
Pannen, B.H.2
-
61
-
-
84870409744
-
Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning
-
[61] Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med 2012; 186: 1095-101.
-
(2012)
Am J Respir Crit Care Med
, vol.186
, pp. 1095-1101
-
-
Hampson, N.B.1
Piantadosi, C.A.2
Thom, S.R.3
Weaver, L.K.4
-
62
-
-
33747609353
-
Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3
-
[62] Bani-Hani MG, Greenstein D, Mann BE, Green CJ, Motterlini R. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3. J Pharmacol Exp Ther 2006; 318: 1315-22.
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 1315-1322
-
-
Bani-Hani, M.G.1
Greenstein, D.2
Mann, B.E.3
Green, C.J.4
Motterlini, R.5
-
63
-
-
0037622140
-
Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities
-
[63] Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90: E17-24.
-
(2002)
Circ Res
, vol.90
, pp. 17-24
-
-
Motterlini, R.1
Clark, J.E.2
Foresti, R.3
Sarathchandra, P.4
Mann, B.E.5
Green, C.J.6
-
64
-
-
0141919529
-
Bioactivity and pharmacological actions of carbon monoxidereleasing molecules
-
[64] Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxidereleasing molecules. Curr Pharm Des 2003; 9: 2525-39.
-
(2003)
Curr Pharm Des
, vol.9
, pp. 2525-2539
-
-
Motterlini, R.1
Mann, B.E.2
Johnson, T.R.3
Clark, J.E.4
Foresti, R.5
Green, C.J.6
-
65
-
-
0041733077
-
Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule
-
[65] Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93: e2-8.
-
(2003)
Circ Res
, vol.93
, pp. 2-8
-
-
Clark, J.E.1
Naughton, P.2
Shurey, S.3
-
66
-
-
84856145785
-
CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke
-
[66] Yabluchanskiy A, Sawle P, Homer-Vanniasinkam S, Green CJ, Foresti R, Motterlini R. CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke. Crit Care Med 2012; 40: 544-52.
-
(2012)
Crit Care Med
, vol.40
, pp. 544-552
-
-
Yabluchanskiy, A.1
Sawle, P.2
Homer-Vanniasinkam, S.3
Green, C.J.4
Foresti, R.5
Motterlini, R.6
-
67
-
-
79955544009
-
An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis
-
[67] Sheikh SZ, Hegazi RA, Kobayashi T, et al. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol 2011; 186: 5506-13.
-
(2011)
J Immunol
, vol.186
, pp. 5506-5513
-
-
Sheikh, S.Z.1
Hegazi, R.A.2
Kobayashi, T.3
-
68
-
-
80054941639
-
Inhibition of nitric oxidestimulated vasorelaxation by carbon monoxide-releasing molecules
-
[68] Marazioti A, Bucci M, Coletta C, et al. Inhibition of nitric oxidestimulated vasorelaxation by carbon monoxide-releasing molecules. Arterioscler Thromb Vasc Biol 2011; 31: 2570-6.
-
(2011)
Arterioscler Thromb Vasc Biol
, vol.31
, pp. 2570-2576
-
-
Marazioti, A.1
Bucci, M.2
Coletta, C.3
-
69
-
-
35748959038
-
Hydrogen sulphide and its therapeutic potential
-
[69] Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-35.
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 917-935
-
-
Szabó, C.1
-
70
-
-
70350452015
-
Bench-tobedside review: Hydrogen sulfide--the third gaseous transmitter: Applications for critical care
-
[70] Wagner F, Asfar P, Calzia E, Radermacher P, Szabó C. Bench-tobedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care. Crit Care 2009; 13: 213.
-
(2009)
Crit Care
, vol.13
, pp. 213
-
-
Wagner, F.1
Asfar, P.2
Calzia, E.3
Radermacher, P.4
Szabó, C.5
-
71
-
-
42549151948
-
Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury
-
[71] Tamizhselvi R, Moore PK, Bhatia M. Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. Pancreas 2008; 36: e24-31.
-
(2008)
Pancreas
, vol.36
-
-
Tamizhselvi, R.1
Moore, P.K.2
Bhatia, M.3
-
72
-
-
33744817050
-
Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse
-
[72] Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1193-201.
-
(2006)
Am J Physiol Lung Cell Mol Physiol
, vol.290
, pp. 20-1193
-
-
Zhang, H.1
Zhi, L.2
Moore, P.K.3
Bhatia, M.4
-
73
-
-
27144558325
-
Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia
-
[73] Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 2005; 146: 498-505.
-
(2005)
Br J Pharmacol
, vol.146
, pp. 498-505
-
-
Collin, M.1
Anuar, F.B.2
Murch, O.3
Bhatia, M.4
Moore, P.K.5
Thiemermann, C.6
-
74
-
-
21744443081
-
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse
-
[74] Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-8.
-
(2005)
FASEB J
, vol.19
, pp. 1196-1198
-
-
Li, L.1
Bhatia, M.2
Zhu, Y.Z.3
-
75
-
-
34848828558
-
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function
-
[75] Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-5.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 15560-15565
-
-
Elrod, J.W.1
Calvert, J.W.2
Morrison, J.3
-
76
-
-
79961075767
-
Inflammatory effects of hypothermia and inhaled H2S during resuscitated, hyperdynamic murine septic shock
-
[76] Wagner F, Wagner K, Weber S, et al. Inflammatory effects of hypothermia and inhaled H2S during resuscitated, hyperdynamic murine septic shock. Shock 2011; 35: 396-402.
-
(2011)
Shock
, vol.35
, pp. 396-402
-
-
Wagner, F.1
Wagner, K.2
Weber, S.3
-
77
-
-
57049151773
-
The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: Chemical mechanism and physiological significance
-
[77] Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr 2008; 40: 533-9.
-
(2008)
J Bioenerg Biomembr
, vol.40
, pp. 533-539
-
-
Cooper, C.E.1
Brown, G.C.2
-
78
-
-
77954620098
-
Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemiainduced heart failure in mice
-
[78] Calvert JW, Elston M, Nicholson CK, et al. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemiainduced heart failure in mice. Circulation 2010; 122: 11-9.
-
(2010)
Circulation
, vol.122
, pp. 11-19
-
-
Calvert, J.W.1
Elston, M.2
Nicholson, C.K.3
-
79
-
-
44249088564
-
The orphan nuclear receptor, NOR-1, a target of betaadrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle
-
[79] Pearen MA, Myers SA, Raichur S, Ryall JG, Lynch GS, Muscat GE. The orphan nuclear receptor, NOR-1, a target of betaadrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 2008; 149: 2853-65.
-
(2008)
Endocrinology
, vol.149
, pp. 2853-2865
-
-
Pearen, M.A.1
Myers, S.A.2
Raichur, S.3
Ryall, J.G.4
Lynch, G.S.5
Muscat, G.E.6
-
80
-
-
33644876210
-
DrugBank: A comprehensive resource for in silico drug discovery and exploration
-
[80] Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006; 34: D668-72.
-
(2006)
Nucleic Acids Res
, vol.34
, pp. 72-668
-
-
Wishart, D.S.1
Knox, C.2
Guo, A.C.3
-
81
-
-
66149149851
-
Structure-based discovery of beta2-adrenergic receptor ligands
-
[81] Kolb P, Rosenbaum DM, Irwin JJ, Fung JJ, Kobilka BK, Shoichet BK. Structure-based discovery of beta2-adrenergic receptor ligands. Proc Natl Acad Sci USA 2009; 106: 6843-8.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 6843-6848
-
-
Kolb, P.1
Rosenbaum, D.M.2
Irwin, J.J.3
Fung, J.J.4
Kobilka, B.K.5
Shoichet, B.K.6
-
82
-
-
34247526984
-
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
-
[82] Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 2007; 7: 357-69.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 357-369
-
-
Liby, K.T.1
Yore, M.M.2
Sporn, M.B.3
-
83
-
-
56649083534
-
Dual roles of Nrf2 in cancer
-
[83] Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res 2008; 58: 262-70.
-
(2008)
Pharmacol Res
, vol.58
, pp. 262-270
-
-
Lau, A.1
Villeneuve, N.F.2
Sun, Z.3
Wong, P.K.4
Zhang, D.D.5
-
85
-
-
0037569694
-
Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidantresponsive element
-
[85] Balogun E, Hoque M, Gong P, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidantresponsive element. Biochem J 2003; 371: 887-95.
-
(2003)
Biochem J
, vol.371
, pp. 887-895
-
-
Balogun, E.1
Hoque, M.2
Gong, P.3
-
86
-
-
0036479330
-
A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway
-
[86] Morimitsu Y, Nakagawa Y, Hayashi K, et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem 2002; 277: 3456-63.
-
(2002)
J Biol Chem
, vol.277
, pp. 3456-3463
-
-
Morimitsu, Y.1
Nakagawa, Y.2
Hayashi, K.3
-
87
-
-
66749132810
-
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription
-
[87] Yang L, Calingasan NY, Thomas B, et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One 2009; 4: e5757.
-
(2009)
Plos One
, vol.4
-
-
Yang, L.1
Calingasan, N.Y.2
Thomas, B.3
-
88
-
-
0033836436
-
Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor
-
[88] Satoh T, Furuta K, Tomokiyo K, et al. Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor. J Neurochem 2000; 75: 1092-102.
-
(2000)
J Neurochem
, vol.75
, pp. 1092-1102
-
-
Satoh, T.1
Furuta, K.2
Tomokiyo, K.3
-
89
-
-
19744371361
-
Pleiotropic renal actions of erythropoietin
-
[89] Chatterjee PK. Pleiotropic renal actions of erythropoietin. Lancet 2005; 365: 1890-2.
-
(2005)
Lancet
, vol.365
, pp. 1890-1892
-
-
Chatterjee, P.K.1
-
90
-
-
77953808996
-
Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart
-
[90] Carraway MS, Suliman HB, Jones WS, Chen CW, Babiker A, Piantadosi CA. Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart. Circ Res 2010; 106: 1722-30.
-
(2010)
Circ Res
, vol.106
, pp. 1722-1730
-
-
Carraway, M.S.1
Suliman, H.B.2
Jones, W.S.3
Chen, C.W.4
Babiker, A.5
Piantadosi, C.A.6
-
91
-
-
79955396662
-
A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure
-
[91] Bergmann MW, Haufe S, von Knobelsdorff-Brenkenhoff F, et al. A pilot study of chronic, low-dose epoetin-{beta} following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure. Eur J Heart Fail 2011; 13: 560-8.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 560-568
-
-
Bergmann, M.W.1
Haufe, S.2
Von Knobelsdorff-Brenkenhoff, F.3
-
92
-
-
0034671934
-
Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts
-
[92] Ogilvie M, Yu X, Nicolas-Metral V, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000; 275: 39754-61.
-
(2000)
J Biol Chem
, vol.275
, pp. 39754-39761
-
-
Ogilvie, M.1
Yu, X.2
Nicolas-Metral, V.3
-
93
-
-
70349328535
-
Erythropoietin signaling promotes transplanted progenitor cell survival
-
[93] Jia Y, Warin R, Yu X, Epstein R, Noguchi CT. Erythropoietin signaling promotes transplanted progenitor cell survival. FASEB J 2009; 23: 3089-99.
-
(2009)
FASEB J
, vol.23
, pp. 3089-3099
-
-
Jia, Y.1
Warin, R.2
Yu, X.3
Epstein, R.4
Noguchi, C.T.5
-
94
-
-
67651243835
-
Erythropoietin overexpression protects against diet-induced obesity in mice through increased fat oxidation in muscles
-
[94] Hojman P, Brolin C, Gissel H, et al. Erythropoietin overexpression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One 2009; 4: e5894.
-
(2009)
Plos One
, vol.4
-
-
Hojman, P.1
Brolin, C.2
Gissel, H.3
-
95
-
-
84855703353
-
Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production
-
[95] Teng R, Gavrilova O, Suzuki N, et al. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2011; 2: 520.
-
(2011)
Nat Commun
, vol.2
, pp. 520
-
-
Teng, R.1
Gavrilova, O.2
Suzuki, N.3
-
96
-
-
84866274600
-
Erythropoietin treatment enhances muscle mitochondrial capacity in humans
-
[96] Plenge U, Belhage B, Guadalupe-Grau A, et al. Erythropoietin treatment enhances muscle mitochondrial capacity in humans. Front Physiol 2012; 3: 50.
-
(2012)
Front Physiol
, vol.3
, pp. 50
-
-
Plenge, U.1
Belhage, B.2
Guadalupe-Grau, A.3
-
97
-
-
33845399894
-
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha
-
[97] Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-22.
-
(2006)
Cell
, vol.127
, pp. 1109-1122
-
-
Lagouge, M.1
Argmann, C.2
Gerhart-Hines, Z.3
-
98
-
-
33751072349
-
Resveratrol improves health and survival of mice on a high-calorie diet
-
[98] Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-42.
-
(2006)
Nature
, vol.444
, pp. 337-342
-
-
Baur, J.A.1
Pearson, K.J.2
Price, N.L.3
-
99
-
-
77952837883
-
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes
-
[99] Biala A, Tauriainen E, Siltanen A, et al. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Press 2010; 19: 196-205.
-
(2010)
Blood Press
, vol.19
, pp. 196-205
-
-
Biala, A.1
Tauriainen, E.2
Siltanen, A.3
-
100
-
-
1542268988
-
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion
-
[100] Liu HR, Tao L, Gao E, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res 2004; 62: 135-44.
-
(2004)
Cardiovasc Res
, vol.62
, pp. 135-144
-
-
Liu, H.R.1
Tao, L.2
Gao, E.3
-
101
-
-
12744268367
-
Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury
-
[101] Yue TL, Bao W, Gu JL, et al. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. Diabetes 2005; 54: 554-62.
-
(2005)
Diabetes
, vol.54
, pp. 554-562
-
-
Yue, T.L.1
Bao, W.2
Gu, J.L.3
-
102
-
-
0038460061
-
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction
-
[102] Lygate CA, Hulbert K, Monfared M, Cole MA, Clarke K, Neubauer S. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. Cardiovasc Res 2003; 58: 632-7.
-
(2003)
Cardiovasc Res
, vol.58
, pp. 632-637
-
-
Lygate, C.A.1
Hulbert, K.2
Monfared, M.3
Cole, M.A.4
Clarke, K.5
Neubauer, S.6
-
103
-
-
13944284526
-
PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs
-
[103] Xu Y, Gen M, Lu L, et al. PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2005; 288: H1314-23.
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.288
, pp. 123-1314
-
-
Xu, Y.1
Gen, M.2
Lu, L.3
-
104
-
-
75549083493
-
Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure
-
[104] Thandapilly SJ, Wojciechowski P, Behbahani J, et al. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 2010; 23: 192-6.
-
(2010)
Am J Hypertens
, vol.23
, pp. 192-196
-
-
Thandapilly, S.J.1
Wojciechowski, P.2
Behbahani, J.3
-
105
-
-
80054736902
-
Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure
-
[105] Rimbaud S, Ruiz M, Piquereau J, et al. Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One 2011; 6: e26391.
-
(2011)
Plos One
, vol.6
-
-
Rimbaud, S.1
Ruiz, M.2
Piquereau, J.3
-
106
-
-
84860558348
-
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease
-
[106] Magyar K, Halmosi R, Palfi A, et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 2012; 50: 179-87.
-
(2012)
Clin Hemorheol Microcirc
, vol.50
, pp. 179-187
-
-
Magyar, K.1
Halmosi, R.2
Palfi, A.3
-
107
-
-
33745962138
-
Therapeutic potential of resveratrol: The in vivo evidence
-
[107] Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5: 493-506.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 493-506
-
-
Baur, J.A.1
Sinclair, D.A.2
-
108
-
-
3943071801
-
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
-
[108] Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004; 430: 686-9.
-
(2004)
Nature
, vol.430
, pp. 686-689
-
-
Wood, J.G.1
Rogina, B.2
Lavu, S.3
-
109
-
-
33846414379
-
Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management
-
[109] Halimi S. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management. Diabetes Metab 2006; 32: 555-6.
-
(2006)
Diabetes Metab
, vol.32
, pp. 555-556
-
-
Halimi, S.1
-
110
-
-
80052528089
-
Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes
-
[110] Larsen S, Stride N, Hey-Mogensen M, et al. Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes. Diabetologia 2011; 54: 1427-36.
-
(2011)
Diabetologia
, vol.54
, pp. 1427-1436
-
-
Larsen, S.1
Stride, N.2
Hey-Mogensen, M.3
-
111
-
-
12144291275
-
Thiazolidinediones, like metformin, inhibit respiratory complex I: A common mechanism contributing to their antidiabetic actions?
-
[111] Brunmair B, Staniek K, Gras F, et al. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 2004; 53: 1052-9.
-
(2004)
Diabetes
, vol.53
, pp. 1052-1059
-
-
Brunmair, B.1
Staniek, K.2
Gras, F.3
-
112
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
[112] Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-74.
-
(2001)
J Clin Invest
, vol.108
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
-
113
-
-
0036299982
-
Metformin increases AMPactivated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
-
[113] Musi N, Hirshman MF, Nygren J, et al. Metformin increases AMPactivated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002; 51: 2074-81.
-
(2002)
Diabetes
, vol.51
, pp. 2074-2081
-
-
Musi, N.1
Hirshman, M.F.2
Nygren, J.3
-
114
-
-
80053163909
-
AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise
-
[114] O'Neill HM, Maarbjerg SJ, Crane JD, et al. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 2011; 108: 16092-7.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 16092-16097
-
-
O'neill, H.M.1
Maarbjerg, S.J.2
Crane, J.D.3
-
115
-
-
77952741468
-
Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
-
[115] Hou X, Song J, Li XN, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010; 396: 199-205.
-
(2010)
Biochem Biophys Res Commun
, vol.396
, pp. 199-205
-
-
Hou, X.1
Song, J.2
Li, X.N.3
-
116
-
-
34547545892
-
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha
-
[116] Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 2007; 104: 12017-22.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 12017-12022
-
-
Jäger, S.1
Handschin, C.2
St-Pierre, J.3
Spiegelman, B.M.4
-
117
-
-
84865031202
-
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
-
[117] Vazquez-Martin A, Cufi S, Corominas-Faja B, Oliveras-Ferraros C, Vellon L, Menendez JA. Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemness. Aging (Albany NY) 2012; 4: 393-401.
-
(2012)
Aging (Albany NY)
, vol.4
, pp. 393-401
-
-
Vazquez-Martin, A.1
Cufi, S.2
Corominas-Faja, B.3
Oliveras-Ferraros, C.4
Vellon, L.5
Menendez, J.A.6
-
118
-
-
67349276169
-
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
-
[118] Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458: 1056-60.
-
(2009)
Nature
, vol.458
, pp. 1056-1060
-
-
Cantó, C.1
Gerhart-Hines, Z.2
Feige, J.N.3
-
119
-
-
22544469153
-
AMP-activated protein kinase: A key stress signaling pathway in the heart
-
[119] Young LH, Li J, Baron SJ, Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 2005; 15: 110-8.
-
(2005)
Trends Cardiovasc Med
, vol.15
, pp. 110-118
-
-
Young, L.H.1
Li, J.2
Baron, S.J.3
Russell, R.R.4
-
120
-
-
84859778293
-
Sabatini DM. MTOR signaling in growth control and disease
-
[120] Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149: 274-93.
-
(2012)
Cell
, vol.149
, pp. 274-293
-
-
Laplante, M.1
-
121
-
-
79959483515
-
Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: A longterm analysis of various treatment regimens
-
[121] Gyurus E, Kaposztas Z, Kahan BD. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a longterm analysis of various treatment regimens. Transplant Proc 2011; 43: 1583-92.
-
(2011)
Transplant Proc
, vol.43
, pp. 1583-1592
-
-
Gyurus, E.1
Kaposztas, Z.2
Kahan, B.D.3
-
122
-
-
84857675728
-
The mTOR Signalling Pathway in Human Cancer
-
[122] Populo H, Lopes JM, Soares P. The mTOR Signalling Pathway in Human Cancer. Int J Mol Sci 2012; 13: 1886-918.
-
(2012)
Int J Mol Sci
, vol.13
, pp. 1886-1918
-
-
Populo, H.1
Lopes, J.M.2
Soares, P.3
-
123
-
-
45149108690
-
Caffeine extends yeast lifespan by targeting TORC1
-
[123] Wanke V, Cameroni E, Uotila A, et al. Caffeine extends yeast lifespan by targeting TORC1. Mol Microbiol 2008; 69: 277-85.
-
(2008)
Mol Microbiol
, vol.69
, pp. 277-285
-
-
Wanke, V.1
Cameroni, E.2
Uotila, A.3
-
124
-
-
34547605613
-
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
-
[124] Lee DF, Kuo HP, Chen CT, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007; 130: 440-55.
-
(2007)
Cell
, vol.130
, pp. 440-455
-
-
Lee, D.F.1
Kuo, H.P.2
Chen, C.T.3
-
125
-
-
42949139481
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint
-
[125] Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-26.
-
(2008)
Mol Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
-
126
-
-
21844441151
-
Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease
-
[126] Liu J, Ames BN.: Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr Neurosci 2005; 8: 67-89.
-
(2005)
Nutr Neurosci
, vol.8
, pp. 67-89
-
-
Liu, J.1
Ames, B.N.2
-
127
-
-
48449104125
-
A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats
-
[127] Shen W, Hao J, Tian C, et al. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS One 2008; 3: e2328.
-
(2008)
Plos One
, vol.3
-
-
Shen, W.1
Hao, J.2
Tian, C.3
-
128
-
-
36649024590
-
R-alpha-lipoic acid and acetyl-Lcarnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes
-
[128] Shen W, Liu K, Tian C, et al. R-alpha-lipoic acid and acetyl-Lcarnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 2008; 51: 165-74.
-
(2008)
Diabetologia
, vol.51
, pp. 165-174
-
-
Shen, W.1
Liu, K.2
Tian, C.3
-
129
-
-
33847071146
-
Targeting antioxidants to mitochondria by conjugation to lipophilic cations
-
[129] Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007; 47: 629-56.
-
(2007)
Annu Rev Pharmacol Toxicol
, vol.47
, pp. 629-656
-
-
Murphy, M.P.1
Smith, R.A.2
-
131
-
-
74149087396
-
Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice
-
[131] Rodriguez-Cuenca S, Cochemé HM, Logan A, et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010; 48: 161-72.
-
(2010)
Free Radic Biol Med
, vol.48
, pp. 161-172
-
-
Rodriguez-Cuenca, S.1
Cochemé, H.M.2
Logan, A.3
-
132
-
-
77955792985
-
A double-blind, placebocontrolled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
-
[132] Snow BJ, Rolfe FL, Lockhart MM, et al. A double-blind, placebocontrolled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord 2010; 25: 1670-4.
-
(2010)
Mov Disord
, vol.25
, pp. 1670-1674
-
-
Snow, B.J.1
Rolfe, F.L.2
Lockhart, M.M.3
-
133
-
-
77956496245
-
The mitochondria-targeted antioxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
-
[133] Gane EJ, Weilert F, Orr DW, et al. The mitochondria-targeted antioxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 2010; 30: 1019-26.
-
(2010)
Liver Int
, vol.30
, pp. 1019-1026
-
-
Gane, E.J.1
Weilert, F.2
Orr, D.W.3
-
134
-
-
79953182648
-
Manganese complexes displaying superoxide dismutase activity: A balance between different factors
-
[134] Iranzo O. Manganese complexes displaying superoxide dismutase activity: a balance between different factors. Bioorg Chem 2011; 39: 73-87.
-
(2011)
Bioorg Chem
, vol.39
, pp. 73-87
-
-
Iranzo, O.1
-
135
-
-
0029776817
-
EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated ironoverloaded rat heart from functional and structural damage induced by ischemia/reperfusion
-
[135] Pucheu S, Boucher F, Sulpice T, et al. EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated ironoverloaded rat heart from functional and structural damage induced by ischemia/reperfusion. Cardiovasc Drugs Ther, 1996; 10: 331-9.
-
(1996)
Cardiovasc Drugs Ther
, vol.10
, pp. 331-339
-
-
Pucheu, S.1
Boucher, F.2
Sulpice, T.3
-
136
-
-
73249117009
-
Antioxidant, EUK-8, prevents murine dilated cardiomyopathy
-
[136] Kawakami S, Matsuda A, Sunagawa T, et al. Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ J 2009; 73: 2125-34.
-
(2009)
Circ J
, vol.73
, pp. 2125-2134
-
-
Kawakami, S.1
Matsuda, A.2
Sunagawa, T.3
-
137
-
-
33746789436
-
EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant
-
[137] van Empel VP, Bertrand AT, van Oort RJ, et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol 2006; 48: 824-32.
-
(2006)
J am Coll Cardiol
, vol.48
, pp. 824-832
-
-
Van Empel, V.P.1
Bertrand, A.T.2
Van Oort, R.J.3
|